摘要
糖尿病患者的皮肤和角膜伤口是一个重要的医疗负担。微小核糖核酸是小的非编码核糖核酸,在转录后水平调控蛋白基因的表达。研究发现微小核糖核酸参与创面愈合的各个阶段。微小核糖核酸失调可导致受损或糖尿病患者皮肤和角膜伤口愈合延迟。在这里,我们提出了一个涉及糖尿病皮肤和角膜伤口愈合的微小核糖核酸的文献以及那些作为糖尿病伤口愈合的潜在生物标志物的综合概述。
关键词: 微小核糖核酸,伤口愈合,皮肤,角膜,糖尿病的发病机制。
Current Molecular Medicine
Title:Small RNAs Play Big Roles: MicroRNAs in Diabetic Wound Healing
Volume: 16 Issue: 6
Author(s): F. Fahs, X.-L. Bi, F.-S. Yu, L. Zhou, Q.-S. Mi
Affiliation:
关键词: 微小核糖核酸,伤口愈合,皮肤,角膜,糖尿病的发病机制。
摘要: Skin and corneal wounds in diabetics are a major healthcare burden. MicroRNAs are small, non-coding RNAs that post-transcriptionally regulate the expression of proteincoding genes. Studies have identified microRNAs involved in all phases of wound healing. The dysregulation of microRNAs can contribute to impaired or delayed skin and corneal wound healing in diabetics. Here, we present a comprehensive review of the literature involving microRNAs in diabetic skin and corneal wound healing as well as those serving as potential biomarkers for diabetic wound healing.
Export Options
About this article
Cite this article as:
F. Fahs, X.-L. Bi, F.-S. Yu, L. Zhou, Q.-S. Mi , Small RNAs Play Big Roles: MicroRNAs in Diabetic Wound Healing, Current Molecular Medicine 2016; 16 (6) . https://dx.doi.org/10.2174/1566524016666160607091156
DOI https://dx.doi.org/10.2174/1566524016666160607091156 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Alternative Approach for Mitigation of Doxorubicin-Induced Cardiotoxicity using Herbal Agents
Current Clinical Pharmacology Receptor-Based Computational Screening of Compound Databases: The Main Docking-Scoring Engines
Current Protein & Peptide Science Clinical Management of Diabetes Mellitus in the Older Adult Patient
Current Diabetes Reviews Editorial from Guest Editor: Current Management of Sleep Apnea and Comorbidities
Current Respiratory Medicine Reviews Essential Oils with Microbicidal and Antibiofilm Activity
Current Pharmaceutical Biotechnology Potential Impact of Genetic Variants in Nrf2 Regulated Antioxidant Genes and Risk Prediction of Diabetes and Associated Cardiac Complications
Current Medicinal Chemistry Editorial: Time for Earlier and More Intensive Preventive Therapy
Current Vascular Pharmacology Optimized Model for Cervical Cancer Detection Using Binary Cuckoo Search
Recent Patents on Computer Science Calcium Sensitizers in Cardiac Surgery: Who, When, How and Why?
Current Vascular Pharmacology When Cells Become a Drug. Endothelial Progenitor Cells for Cardiovascular Therapy: Aims and Reality
Recent Patents on Cardiovascular Drug Discovery Recent Advances in Exercise Testing
Current Cardiology Reviews Usefulness of Magnetic Resonance Imaging in Cardiac and Enovascular Intervention
Current Medical Imaging Antidyslipidemic Capacity of <i>Cleome arabica</i> (L.) in Streptozotocin-Induced Diabetic Rats
Cardiovascular & Hematological Agents in Medicinal Chemistry The Role of Nitric Oxide on Endothelial Function
Current Vascular Pharmacology Recent Progress in Pharmacological and Non-Pharmacological Treatment Options of Major Depression
Current Pharmaceutical Design Neuroimmune Activation in Chronic Heart Failure
Endocrine, Metabolic & Immune Disorders - Drug Targets Nitric Oxide-Releasing Biomaterials for Biomedical Applications
Current Medicinal Chemistry Concerns and Hopes for Stem Cell Therapy in Cardiology: Focus on Endothelial Progenitor Cells
Cardiovascular & Hematological Disorders-Drug Targets Avian Genomes: Important Resources for Understanding Vertebrate Biology
Current Genomics Editorial [Hot Topic: Waiting for Action on the Osteoarthritis Front (Guest Editors: Virginia Byers Kraus and Thomas Aigner)]
Current Drug Targets